| Шығарылым |
Бөлім |
Атауы |
Файл |
| Том 30, № 14 (2023) |
Cardiology |
On the issue of improving the safety of antithrombotic therapy in patients with atrial fibrillation and coronary heart disease receiving antithrombotic therapy |
|
| Том 31, № 1 (2024) |
Cardiology |
On the possible relationship between the presence of polymorphic variants of CYP3A4/5 cytochrome genes, their metabolic activity with rivaroxaban pharmacokinetics and the development of bleeding in patients with non-valvular atrial fibrillation and chronic kidney disease |
|
| Том 31, № 1 (2024) |
Cardiology |
Arterial hypertension and cognitive impairment in elderly and senile patients: basic approaches to patient management |
|
| Том 31, № 1 (2024) |
Cardiology |
State of cognitive functions in patients with various forms of atrial fibrillation |
|
| Том 31, № 4 (2024) |
Cardiology |
Pharmacotherapy of elderly multimorbid patients with atrial fibrillation in real clinical practice: practical application of STOPP/START criteria |
|
| Том 31, № 4 (2024) |
Cardiology |
Cognitive status of patients with coronary artery disease and concomitant atrial fibrillation |
|
| Том 31, № 4 (2024) |
Cardiology |
Non-alcoholic fatty liver disease as a trigger of polymorbidity. Is there a way out of the impasse? |
|
| Том 31, № 6 (2024) |
Cardiology |
On the possible relationship between polymorphic variants of the CYP2C19 gene, residual concentration and the presence of bleeding in patients who have suffered acute coronary syndrome and are receiving clopidogrel as part of dual antithrombotic therapy |
|
| Том 31, № 9 (2024) |
Cardiology |
Omega-3 PUFA as a basic element of therapy for patients with hypertriglyceridemia |
|
